Human Immunodeficiency Virus Infections-Neurological Manifestations

Neurological Disorders: Course and Treatment: Second Edition

Volumn , Issue , 2003, Pages 623-646

  Manji, Hadi ^a,b   Guiloff, Roberto ^c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b IPSWICH HOSPITAL   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649320389     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012125831-3/50246-X     Document Type: Chapter

References (166)

1. Adler M. Development of the epidemic. ABC of AIDS 2001, 1-5. BMJ Publishing, London. 5th ed. M. Adler (Ed.).
2. Andreula C.F., Burdi N., Carella A. CNS cryptococcosis in AIDS: spectrum of MR findings. J. Comput. Assist. Tomogr. 1993, 17(3):438-441.
3. Arnaudo E., Dalakas M.C., Shanske E., et al. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine induced myopathy. Lancet 1991, 337:508-510.
4. Arribas J.R., Storch G.A., Clifford D.B., et al. Cytomegalovirus encephalitis. Ann. Intern. Med. 1996, 125:577-587.
5. Backonja M., Beydoun A., Edwards K.R., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998, 280:1831-1836.
6. Barohn R.J., Gronseth G.S., Leforce B.R., et al. Peripheral nervous systgem involvement in a large cohort of human immunodeficiency virus infected individuals. Arch. Neurol. 1993, 50:167-171.
7. Batman P.A., Miller A.R., Sedgwick P.M., et al. Autonomic denervation in jejunal mucosa of homosexual men infected with HIV. AIDS. 1991, 5:1247-1252.
8. Baumgartner J.E., Rachlin J.R., Beckstead J.H., Meeker T.C., Levy R.M., Wara W.M., Rosenblum M.L. Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J. Neurosurg. 1990, 73:206-211.
9. Bennett J.E., Dismukes W.E., Duma R.J., Medoff G., Sande M.A., Gallis H., Leonard J., Fields B.T., Bradshaw M., Haywood H., McGee Z.A., Cate T.R., Berry C.D., Hooton T.M., Collier A.C., et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N. Engl. J. Med. 1979, 301:126-131.
10. Berengeur J., Moreno S., Laguna F., et al. Tuberculous meningitis in patients with the human immunodeficiency virus. N. Engl. J. Med. 1992, 326:668-672.
11. Berger J.R. Neurosyphilis in human immunodeficiency virus type I seropositive individuals: A prospective study. Arch. Neurol. 1991, 48:700-702.
12. Berger J.R., Levy R.M., Flomenhoft D., et al. Predictive factors for prolonged survivial in acquired immunodeficiency syndrome acquired progressive multifocal leucoencephalopathy. Ann. Neurol. 1998, 44:341-349.
13. Berger J.R., Pall L., Lanska D., et al. Progressive multifocal leucoencephalopathy in patients with HIV infection. J. Neurovirol. 1998, 4:59-68.
14. BHIVA Writing Committee on behalf of the BHIVA Executive Committee BHIVA guidelines for the treatment of HIV infected adults with antiretroviral therapy. HIV Medicine 2001, 2:276-313.
15. Bishburg E., Sunderam E., Reichman L.B., et al. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann. Intern. Med. 1986, 105:210-213.
16. Bissuel F., Berruyer M., Causse X., et al. Acquired protein S deficiency: correlation with advanced disease in HIV-1 infected patients. J. Acquir. Immun. Defic. Syndr. 1992, 5:484-489.
17. Bossolasco S., Nilsson A., de Milito A., et al. Soluble CD 23 in cerebrospinal fluid: a marker of AIDS related non-Hodgkin's lymphoma in the brain. AIDS 2001, 15:1109-1113.
18. Bowman F.H., Skolsky R., Hes D., et al. Variable progression of HIV dementia. Neurology 1998, 50:1814-1820.
19. Bozzette S.A., Larsen R.A., Chiu J., et al. A placebo controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in AIDS. N. Engl. J. Med. 1991, 324:580-584.
20. Bradley W.G., Verma A. Painful vasculitic neuropathy: relief of pain with prednisolone therapy. Neurology 1996, 47:1446-1451.
21. Brettle R. HIV and AIDS: natural History of HIV/AIDS. Medicine 2001, 12-15. Medicine Publishing Co. A. Lever (Ed.).
22. Brilla R., Nabavi D.G., Schulte-Altedorneburg G., et al. Cerebral vasculopathy in HIV infection revealed by trans-cranial doppler. Stroke 1999, 30:811-813.
23. Brinkman R., Schwinn A., Narayan O., et al. Human immunodeficiency virus infection in microglia: Correlation between cells infected in the brain and cells cultured from infectious brain tissue. Ann. Neurol. 1992, 31:361-365.
24. Budka H., Wiley C.A., Kleihues P., et al. HIV associated disease of the nervous system: review of the nomenclature and proposal for neuropathology based terminology. Brain Path. 1991, 1:143-152.
25. Calabrese L.H., Estes M., Yen-Lieberman B., et al. Systemic vasculitis in association with human immunodeficiency virus infection. Arthritis Rheum. 1989, 32:569-576.
26. Carne C.A., Tedder R.S., Smith A., et al. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet 1985, ii:1206-1208.
27. Childs E.A., Lyles R.S., Selnes O.A., et al. Plasma viral load and CD4 cell count predict HIV associated dementia and sensory neuropathy. Neurology 1999, 52:607-613.
28. Chimelli L., Scaravelli F. Morphological changes in the autonomic neurous system of patients with AIDS. Proceedings of the Seventh International Conference on Neuroscience of HIV infection 1991, 89.
29. Chowdhury M.M., Kundu M., Khalili K., et al. GA/GC rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCV 1, in cells derived from the central nervous system. Oncogene. 1993, 8:887-892.
30. Chuck S.L., Sande M.A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N. Engl. J. Med. 1989, 321:794-799.
31. Cirillo S.F., Rosenblum M.L. Use of Ct and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J. Neurosurg. 1990, 73:720-724.
32. Cinque P., Scarpellini P., Vago L., et al. Diagnosis of central nervous system complications in HIV infected patients: cerebrospinal fluid analysis by polymerase chain reaction. AIDS. 1996, 11:1-17.
33. Clifford D. Human immunodeficiency virus associated dementia. Arch. Neurol. 2000, 57:321-324.
34. Clifford D., Yiannoustsos C., Glickman M., et al. HAART improves prognosis in HIV-associated progressive multifocal leucoencephalopathy. Neurology 1999, 52:623-625.
35. Cobbs C.G., Warner J.F., Alling D.W. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N. Engl. J. Med. 1979, 310:126-131.
36. Connor M.D., Lammie G.A., Bell J.E., et al. Cerebral infarction in adult AIDS patients. Stroke. 2000, 31:2117-2126.
37. Cornblath D.R., McArthur J.C. Predominantly sensory neuropathy in patients with AIDS and AIDS related complex. Neurology 1988, 38:794-796.
38. Cornblath D.R., McArthur J.C., Kennedy P.G.E., et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotrophic virus type III infection. Ann. Neurol. 1987, 21:32-40.
39. Crowe S.M., Carlin B., Stewark K.L., et al. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV infected persons. J. Infect Dis. 1991, 4:770-776.
40. Dalakas M.C., Illa I., Pezeshkpour G.H., et al. Mitochondrial myopathy caused by long term zidovudine therapy. N. Engl. J. Med. 1990, 322:1098-1105.
41. Dalakas M.C., Pezeshkpour G., Gravell M., et al. Polymyositis associated with AIDS retrovirus. JAMA 1986, 256:2381-2383.
42. De Angelis L.M., Wong E., Rosenblum M., et al. Epstein-Barr virus in Aids and non Aids primary central nervous system lymphoma. Cancer. 1992, 70:1607-1611.
43. De la Monte S.M., Gabuzda D.H., Ho D.D., et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann. Neurol. 1988, 23:485-492.
44. De Luca A., Fantoni M., Tartaglione T., et al. Response to cidofovir after failure of antiretroviral therapy alone in AIDS associated progressive multifocal leucoencephalopathy. Neurology 2000, 52:891-892.
45. Denning D.W., Anderson J., Rudge P., et al. Acute myelopathy associated with primary infection with human immunodeficiency virus. BMJ. 1987, 294:143-149.
46. Dirocco A., Tagliati M., Danisi F., et al. A pilot study of I-methionine for the treatment of AIDS associated vacuolar myelopathy. Neurology 1998, 51:266-268.
47. Drabick J.J., Tramont E.C. Utility of the VDRL test in HIV seropositive patients. N. Engl. J. Med. 1990, 322:271.
48. Dunbar N., Brew B. Neuropsychological dysfunction in AIDS: a review. J. NeuroAIDS 1996, 1(3):73-102.
49. Ellis R.J., Hsia K., Spector S.A., et al. Cerebrospinal fluid human immunodeficiency virus type-1RNA levels in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann. Neurol. 1997, 42:679-688.
50. Eng R.H.K., Bishburg E., Smith S.M., Kapila R. Cryptococcal infections in patients with acquired immune deficiency syndrome. Am. J. Med. 1986, 81:19-23.
51. Enting R.H., Hoetelmans R.M., Lange J.M., et al. Antiretroviral drugs and the central nervous system. AIDS. 1998, 12:1941-1955.
52. Epstein L.G., Gendleman H.E. Human immunodeficiency virus type-1 infection of the nervous system: pathogenic mechanisms. Ann. Neurol. 1993, 33:429-436.
53. Famularo G., Moretti S., Marcellini S., et al. Acetyl carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS. 1997, 11:185-190.
54. Fuller G.N., Jacobs J.M., Guiloff R.J. Nature and incidence of peripheral nerve syndromes in HIV infection. J. Neurol. Neurosurg. Psychiatr. 1993, 56:372-381.
55. Gherardi R.K., Chretien F., Deelfau-Larue M.-H., et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome. Neurology. 1998, 50:1041-1044.
56. Gillespie S.M., Chang Y., Lemp G., et al. Progressive multifocal leucoencephalopathy in persons infected with the human immunodeficiency virus. San Francisco, 1981-1989. Ann. Neurol. 1991, 30:597-604.
57. Glass J.D., Wesselingh S.L., Selnes O.A., et al. Clinical-neuropathological correlation in HIV associated dementia. Neurology. 1993, 43:2230-2237.
58. Glesby M.J., Moore R.D., Cjaisson R.E. Clinical spectrum of herpes zoster in adults infected with human deficiency virus. Clin. Infect. Dis. 1995, 21:370-375.
59. Gottlieb M.S., Schroff R., Schanker H.M., et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 1981, 305:1425-1431.
60. Grant, I. H., Gold, J., Rosenblum, M. et al. Toxoplasma gondii serology in HIV infected patients: The development of CNS toxoplasmosis in AIDS. AIDS4, 519-521.
61. Gray F., Geny C., Dournon E., Fenelon G., Lionnet F., Gherardi R. Neuropathological evidence that zidovudine reduces incidence of HIV-infection of brain. Lancet 1991, 337:852-853.
62. Gray F., Gherardi R., Wingate E., Singate J., Fenelon G., Gaston A., Sobel A. Diffuse encephalitic cerebral toxoplasmosis in AIDS: Report of four cases. J. Neurol. 1989, 236:273-277.
63. Graybill J.R., Sobel J., Saag M., et al. Diagnosis and management of intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin. Infect. Dis. 2000, 30:47-54.
64. Guiloff R.J. Neurological opportunistic infections in Central London. J. R. Soc. Med. 1989, 82:278-280.
65. Guiloff R.J., Fuller G.N. Other neurological diseases in HIV-1 infection: Clinical aspects. Clinical Neurology: Neurological Aspects of Human Retroviruses 1992, 175-209. Balliere and Tindall, London. P. Rudge (Ed.).
66. Guiloff R.J., Tan S.V. Central nervous system opportunistic infections in HIV disease: clinical aspects. Clinical Neurology: Neurological aspects of human retroviruses 1992, 103-154. Balliere and Tindall, London. P. Rudge (Ed.).
67. Haas J., Bolan G., Larsen S., et al. Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency, virus infection. J. Infect. Dis. 1990, 162:862-866.
68. Hall C., Dafni I., Simpson D., et al. Failure of cytarabine in progressive multifocal leucoencephalopathy associated with human immunodeficiency virus infection. N. Engl. J. Med. 1998, 338:1345-1351.
69. Hamed L.M., Schatz N.J., Galetta S.L. Brainstem ocular motility defects and AIDS. Am. J. Ophthalmol. 1988, 106:437-442.
70. Ho D.D., Pomerantz R.J., Kaplan J.C. Pathogenesis of infection with the human immunodeficiency virus. N. Engl. J. Med. 1987, 278:278-286.
71. Hoffmann M., Berger J., Nath A., et al. Cerebrovascular disease in young, HIV-infected black Africans in the KwaZulu Natal Province of South Africa. J. Neurovirol. 2000, 6:229-236.
72. Holland N.R., Power C., Matthews V.P., et al. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Neurology 1994, 44:507-514.
73. Huang P.P., McMeeking A.A., Stempien M.J., et al. Cytomegalovirus disease presenting as a focal brain mass: report of two cases. Neurosurgery 1997, 40:1074-1078.
74. Huang S.S., Skolansky R.L., Dal Pan G.J., et al. Survival prolongation in HIV-associated progressive multifocal leucoencephalopathy treated with alpha-interferon: an observational study. J. Neurovirol. 1998, 4:324-332.
75. Illa I., Nath A., Dalakas M., et al. Immunocytochemical and virological characteristics of HIV associated inflammatory myopathies. Ann. Neurol. 1991, 29:474-481.
76. Kalayjian R.C., Cohen M.L., Bonomo R., et al. Cytomegalovirus ventriculoencephalitis in AIDS. Medicine 1993, 72:67-77.
77. Kamin S.S., Petito C.K. Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency patients. Hum. Pathol. 1991, 22:816-824.
78. Kieburtz K., Simpson D., Yiannoustous D., et al. A randomised trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. Neurology 1998, 51:1682-1688.
79. Kinloch-de Loës S., Hirschel B., Hoen B., et al. A controlled trial of zidovudine in primary HIV infection. N. Engl. J. Med. 1995, 333:408-413.
80. Kovacs J.A., Kovacs A.A., Polis M., Wright W.C., Gill V.J., Tuazon C.U., Gelmann E.P., Lane H.C., Longfied R., Overturf G., Macher A.M., Fauci A.S., Parrillo J.E., Bennett J.E., Masur H. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 1985, 103:533-538.
81. Kovacs J.A., Masur H. Prophylaxis against opportunistic infections in patients with Human Immunodeficiency Virus Infection. N. Engl. J. Med. 2000, 342:1416-1429.
82. Lanska M.J., Lanska D.J., Schmidley J.W., et al. Syphilitic polyradiculopathy in an HIV positive man. Neurology 1988, 38:1297-1301.
83. Larsen R.A., Leal M.A.E., Chan L.S. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: A randomized trial. Ann. Intern. Med. 1990, 113:183-187.
84. Levine A.M., Sullivan-Halley J., Pike M.C., et al. Human immunodeficiency virus related lymphoma. Prognostic factors predictive of survival. Cancer 1991, 6:2466-2472.
85. Levy J.A. Features of HIV and the host response that influence progression to disease. The Medical Management of AIDS 1990, 233-237. W.B. Saunders, Philadelphia. M.A. Sande, P.A. Volberding (Eds.).
86. Lewis W., Dalakas M.C. Mitochondrial toxicity of antiviral drugs. Nat. Med. 1995, 1:417-422.
87. MacGowan D.J., Scelasa S.N., Waldron M., et al. An ALS like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology 2001, 57:1094-1097.
88. Mahe A., Bruet A., Chabin E., et al. Acute rhabdomyolysis coincident with primary HIV-1 infection. Lancet 1989, ii:454-455.
89. Malessa, R. (1991). Veränderungun am Rückenmark. In "HIV Infektion und Nervensystem." (A. A. Moller and H. Backmund, Eds.), pp. 97-100.
90. Manji H., LeCroix C., Said G. The clinical and laboratory features of HIV-1 associated necrotizing arteritis peripheral neuropathy. J. Neurol. 1997, 244(suppl. 3):S67.
91. Manji H., Miller R. Progressive Multifocal Leucoencephalopathy-progress in the AIDS era (editorial). J. Neurol. Neurosurg. Psychiatry 2001, 69:569-571.
92. Martin C., Solders G., Sonnerberg A., et al. Antiretroviral therapy may improve sensory function in HIV infected patients-a pilot study. Neurology 2000, 54:2120-2127.
93. Masur H., Michelis M.A., Greene J.B., et al. An outbreak of community acquired pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N. Engl. J. Med. 1981, 305:1431-1438.
94. McArthur J.C., Cohen B.A., Farzedegan H., et al. Cerebrospinal fluid abnormalities in homosexual men with and without neuropsychiatric findings. Ann. Neurol. 1988, 23(suppl):S34-S37.
95. McArthur J.C., Hoover D.R., Bacellar M.A., et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993, 43:2245-2252.
96. McArthur J.C., McLernon D.R., Cronin M.F., et al. Relationship between human immunodeficiency virus associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 1997, 42:689-698.
97. McArthur J.C., Yiatannoustsos C., Simpson D.M., et al. A phase 2 trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology 2000, 54:1080-1088.
98. Mhiri C., Baudrimont M., Bonne G., et al. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann. Neurol. 1991, 29:606-614.
99. Miller R.F., Fox J.D., Waite J.C., et al. Herpes simplex virus type 2 encephalitis and concomitant CMV infection in a patient with AIDS. Geritourin Med. 1995, 71:262-264.
100. Miller R.F., Hall-Craggs M.A., Costa D.C., et al. Magnetic resonance imaging, thallium-201 SPECT and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sex. Transm. Infect. 1998, 74(4):258-264.
101. Miller R.G., Storey J.R., Greco C.M. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology 1990, 40:569-574.
102. Moore R.D., Wong W.M., Keruly J.C., et al. Incidence of neuropathy in HIV-1 infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 2000, 14:273-278.
103. Morgello S., Wolfe D., Godfrey E., et al. Mitochondrial abnormalities in HIV associated myopathy. Acta Neuropathol. 1995, 90:366-374.
104. Moulignier A., Authier F.-J., Baudrimort M., et al. Peripheral neuropathy in human immunodeficiency virus infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann. Neurol. 1997, 41:438-445.
105. Moulignier A., Moulonguet A., Pialoux G., et al. Reversible ALS-like disorder in HIV infection. Neurology 2001, 57:995-1001.
106. Musher D.M., Hamill R.J., Baughn R.E., et al. Effect of the human immunodeficiency virus (HIV) on the course of syphilis and on the response to treatment. Ann. Intern. Med. 1990, 113:872-881.
107. Narcisco M., Koizumi K., Koike T., et al. Reversal of HIV associated motor neuron syndrome after highly active antiretroviral therapy. J. Neurol. 2001, 248:233-234.
108. Narciso P., Galgani M.D., Del Grosso B., et al. Acute disseminated encephalitis as a manifestation of primary HIV infection. Neurology 2001, 57:1493-1496.
109. Nishio M., Koizumi K., Moriwaka F., et al. Reversal of HIV associated motor neuron syndrome after HAART (letter). J. Neurol. 2001, 248:233-234.
110. Palella F.J., Delaney K.M., Morrman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 1998, 338:853-860.
111. Perriens J., Piot P. Worldwide epidemiology of HIV infection. Focus on HIV 1993, 3-19. Churchill-Livingstone, Edinburgh. H.C. Neu, J.A. Levy, R.A. Weiss (Eds.).
112. Petito C.K., Cho E.S., Lemann W., et al. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J. Neuropathol. Exp. Neurol. 1986, 45:635-646.
113. Petito C.K., Navia B.A., Cho E.S., et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1985, 312:874-879.
114. Pfister H.W., Einhaupl K.M., Baumlattner U., et al. Dissociated nystagmus as a common symptom of oculomotor disorders in HIV infected patients. Eur. Neurol. 1989, 29:277-280.
115. Pinto A. AIDS and cerebrovascular disease. Stroke. 1996, 27:538-543.
116. Pizzo P.A., Eddy J., Falloon J., et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N. Engl. J. Med. 1988, 319:889-896.
117. Portegies P., de Gans J., Lange J.M.A., Derix M.M.A., Speelman H., Bakker M., Danner S.A., Goudsmit J. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 1989, 299:819-820.
118. Portegies P., Enting R.H., deGaqns J., Algra P.R., Derix M.M.A., Lange J.M.A., Goudsmit J. Presentation and course of AIDS-dementia complex: 10 years of followup in Amsterdam, The Netherlands. AIDS 1993, 7:669-675.
119. Porter S.B., Sande M.A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency sndrome. N. Engl. J. Med. 1992, 327:1643-1648.
120. Post M.J., Hensley G.T., Moskowowitz L.B., et al. Cytomegalic inclusion virus encephalitis in patients with AIDS; CT, clinical and pathologic correlation. AJN 1986, 7:275-280.
121. Powderly W.G. Cryptococcal meningitis and AIDS. Clin. Infect. Dis. 1993, 17:837-842.
122. Powderly W.G., Saag M.S., Cloud G.A., et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1992, 326:793-798.
123. Price R.W. Neuropathy complicating diffuse infiltrative lymphocytosis. Lancet 1998, 352:592-594.
124. Raffi F., Aboulker J.-P., Michelet C., et al. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. AIDS 1997, 11:177-184.
125. Renold C., Sugar A., Chave J.-P., et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Medicine 1992, 71:224-239.
126. Saag M., Powderly W., Cloud G., et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS associated cyptococcal meningitis. N. Engl. J. Med. 1992, 326:83-89.
127. Saag M.S., Powderly W.G., Cloud G.A., Robinson P., Grieco M.H., Sacktor N.C., Bacellar H., Hoover D.R., et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J. Neurovirol. 1996, 2:404-410.
128. Sacktor N., Lyles R.H., Skolasky M.A., et al. HIV associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001, 56:257-260.
129. Sacktor N., Tarwater P.M., Skolasky M.A., et al. CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology 2001, 57:542-544.
130. Said G., Lacroix C., Chemoulli P., et al. Cytomegaloviris neuropathy in acquired immunodeficiency syndrome. A clinical and pathological study. Ann. Neurol. 1991, 29:136-146.
131. Schifitto G., Yiannoutsos C., Simpson D.M., et al. Long-term treatment with recombinant nerve growth factor for HIV associated sensory neuropathy. Neurology 2001, 57:1313-1316.
132. Setinek U., Wondousch E., Jellinger S., et al. CMV infection of the brain in AIDS. Acta Neuropathol. (Berlin) 1995, 90:511-515.
133. Sharkey P.K., Thompson S.E., Sugar A.M., Tuazon C.U., Fisher J.F., Hyslop N., Jacobsen J.M., Hafner R., Dismukes W.E. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N. Engl. J. Med. 1992, 326:83-89. NIAID Mycoses Study Group, AIDS Clinical Trial GroupAIDS Clinical Trial Group.
134. Shlay J.C., Chaloner K., Max M., et al. Acupuncture and amitriptyline for pain due to HIV related neuropathy. JAMA 1998, 280:1590-1595.
135. Sidtis J.J., Gatsonis C., Price R.W., Singer E.J., Collier A.C., Richman D.D., Hirsch M.S., Schaerf F.W., Fischl M.A., Kieburtz K., Simpson D., Koch M.A., Feinberg J., Dafni U. Zidovudine treatment of the AIDS dementia complex: Results of a placebo-controlled trial. Ann. Neurol. 1993, 33:343-349. AIDS Clinical Trials Group.
136. Silber E., Sonnenberg P., Koornhof H.J., et al. Dual infective pathology in patients with cryptococcal meningitis. Neurology 1998, 51:1213-1215.
137. Silva N., O'Bryan L., Medeiros E., et al. Trypanosoma cruzi meningoencephalitis in HIV-1 infected patients. J. Acqr. Immune. Def. Syndr. 1999, 20:342-349.
138. Simpson D.M., Bender A.N. Human immunodeficiency virus associated myopathy: analysis of 11 patients. Ann. Neurol. 1988, 24:79-84.
139. Simpson D.M., Citak K.A., Godfrey E., et al. Myopathies associated with human immunodeficiency virus and zidovudine. Can their effects be distinguished?. Neurology 1993, 43:971-976.
140. Simpson D.M., Dorfman D., Olney R.K., et al. Peptide T in the treatment of painful distal neuropathy associated with AIDS. Neurology 1996, 47:1254-1259.
141. Simpson D.M., Katzenstein D.A., Hughes M.D., et al. Neuromuscular function in HIV infection: analysis of a placebo controlled combination antiretroviral trial. AIDS 1998, 12:2425-2432.
142. Simpson D., Olney R., McArthur J.C., et al. A placebo controlled trial of lamotrigine for painful HIV associated neuropathy. Neurology 2000, 54:2115-2119.
143. Simpson D.M., Tagliati M. Nucleoside analogue-assciated peripheral neuropathy in human immunodeficiency virus infection. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1995, 9:153-161.
144. Sindrup J.H., Weismann K., Wantzin G.L. Syphilis in HTLV-III infected male homosexuals. AIDS Res. 1986, 2:285-288.
145. So Y.T., Holtzman D.T., Abrams D.J., et al. Peripheral neuropathy associated with acquired immune deficiency syndrome: Prevalence and clinical features from a population based survey. Arch. Neurol. 1988, 45:945-948.
146. So Y.T., Olney R.K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann. Neurol. 1994, 35:53-58.
147. Stahl C., Wideman C., Spira T., et al. Protein s deficiency in men with long-term human immunodeficiency virus infection. Blood 1993, 81:1801-1807.
148. Staudinger R., Henry K. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology 2000, 54:267-268.
149. Stimmler M.M., Quismorio F.P., McGhee W.G., et al. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch. Intern. Med. 1989, 149:1833-1835.
150. Sweeny B.J., Manji H., Mller R.F., et al. Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leucoencephalopathy. J. Neurol. Neurosurg. Psychiat. 1994, 57:994-997.
151. Takahasi K., Wesslingh S.I., Griffin D.E., et al. Localisation of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunohistochemistry. Ann. Neurol. 1996, 39:705-711.
152. Tan S.V., Guiloff R.J., Scaravilli F., et al. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Ann. Neurol. 1993, 34:619-622.
153. Toggas S., Masliah E., Rockenstein E., et al. neurotoxicity of viral proteins-HIV-1 gp 120 effects on transgenic mice. Clin. Neuropathol. 1993, 12(Suppl. 1):S4-S5.
154. Toulon P., Lamine M., Ledjev I., et al. Heparin cofactor 11 deficiency in patients infected with the human immunodeficiency virus. Thromb. Haemostat. 1993, 70:730-735.
155. Tross S., Price R.W., Navia B.A., et al. Neuropsychological characterisation of the AIDS dementia complex. AIDS 1988, 2:81-88.
156. Vago L., Nebuloni M., Sala E., et al. Coinfection of the central nervous system by CMV and herpes simplex type 1 and 2 in AIDS patients. Acta Neuropathol 1996, 92:404-408.
157. Van der Hoorst C.M., Gaag M.S., Cloud G.A., et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 1997, 337:15-21.
158. Veenstra J., Krol A., van Praag R.M., et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 1995, 9:1153-1158.
159. Vinters H.V., Kwok M.K., Ho H.W., et al. Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 1989, 112:245-268.
160. Von Einsiedel R.W., Fife T.D., Akaamit A.J., et al. Progressive multifocal leucoencephalopathy in AIDS: a clinicopathologic study and review of the literature. J. Neurol. 1993, 240:391-406.
161. Weber T. Cerebrospinal fluid analysis for the diagnosis of Human Immunodeficiency Virus related neurologic disease. Semin. Neurol. 1999, 19(2):223-233.
162. Wesslingh S.L., Power C., Glass J.D., et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 1993, 33(6):576-582.
163. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type-1 infection. Neurology 1991, 41:778-785. Working Group of the American Academy of Neurology AIDS Task Force.
164. Yechoor V.K., Shandera W.X., Rodriguez P., et al. Tuberculous meningitis among adults with and without HIV infection. Arch. Intern. Med. 1996, 156:1710-1716.
165. Zeman A., Donaghy M. Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention. Genitourin. Med. 1991, 67:345-347.
166. Zuger A., Louie E., Holzman R.S., Simberkoff M.S., Rahal J.J. Maintenance amphotericin B for cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 1986, 85:481-489.